Figueroa CI, Saavedra MD, de la Torres SY, Sánchez LM

Language: Spanish
References: 17
Page:
PDF size: 78.35 Kb.

ABSTRACT

Introduction: eclampsia is a disease of human pregnancy, responsible for a significant increase in the rates of maternal and perinatal morbidity and mortality.
Objective: to study the effectiveness of the use of magnesium sulfate in the treatment of pre-eclampsia.
Methods: an intervention and evaluation study in health services was conducted from June 1st to December 31st, 2011. 98 pregnant women admitted to the Perinatal Care unit were the universe and sample of this study. They had been classified as pre-eclamptic.
Results: 68.36 % of these women were 20-34 years old, 75.51 % were nulliparous. 2.04 % had oligoanuria as response to the drug. 100 % of these patients used hypotensive drugs and hydralazine was mostly used (63.25 %). More than 50 % delivered at the end of pregnancy with healthy weight of the product. 76.50 % of births occurred by cesarean. The most common maternal complication was hypertension, and neonatal depression at birth was present in 7.14 %.
Conclusions: magnesium sulfate treatment was effective because it was able to reduce the number of pregnant women with eclampsia, when using prophylactically.

REFERENCES

1. O Dowd MJ, Philipp EE. Historia de la Ginecología y Obstetricia. Barcelona: Edika Med; 1998. p. 79.

2. Gómez E. Trastornos Hipertensivos Durante el Embarazo. Rev Cubana Obstet Ginecol. 2000;26(2).

3. Rigol O, Cutié E, Santiesteban S, Cabezas E, Farnot U. Obstetricia y Ginecología. La Habana: Ed. Ciencias Médicas; 2006. p. 126-136.

4. Cunningham FG, Gant NF, Leveno KJ, Gilstrap LC, Aut JC. Williams Obstetricia. La Habana: Ed Ciencias Médicas; 2007. p. 489- 509.

5. Balestena J, Fernández R, Hernández A. Comportamiento de la Preeclampsia Grave. Rev Cubana Obstet Ginecol. 2000;27(3):226-32.

6. Schwarcz R, Fessina R, Diverges C. Obstetricia. 6ta ed. Argentina: Ed. El Ateneo; 2005. p. 301-313.

7. Vázquez A, Reina G, Román P, Guzmán R, Méndez A. Trastornos Hipertensivos del Embarazo. Rev Cubana Med. 2005;44(3-4).

8. Vázquez JC, Vázquez J, Namfantche J. Asociación entre hipertensión arterial durante el embarazo, bajo peso al nacer y algunos resultados. Rev Cubana Obstet Ginecol. 2003;29(1).

9. Sintes R, Diáz G, Salas I, Lemus ER, Batista R. Temas de Medicina General Integral. La Habana: Ed. Ciencias Médicas; 2001. p. 801- 804.

10. Rodríguez N, Cutié E, Cordero R. Manual de diagnóstico y tratamiento en Obstetricia y Perinatología. La Habana: Ed Ciencias Médicas. 2000. p. 237-252.

11. Cifuentes R, Canaval H, Prieto C. Obstetricia de alto riesgo. 6ta. ed. Colombia: Ed. Distribuna. 2006. p. 447-484.

12. Orisondo R, Ferrer BE, Penton R. Resultados Obstétricos y Perinatales en 150 pacientes con Hipertensión Arterial. Rev Cubana Obstet Ginecol. 2006;32(3).

13. Scout JR, Disaia PJ, Hammond CHB, Spellacy WN. Danforth. Tratado de Obstetricia y Ginecología. 8va ed. México: McGraw- Hill. Interamericana; 2000. p. 323-342.

14. Vanesa A. Preeclampsia, Fisiopatología y Tratamiento. Rev Bras. Hipertensión. 2006;13(2):88-9.

15. Aure G, Lares M. Evaluación de la Molécula 1 de Adhesión Vascular Como Indicador de Activación Endotelial en la Preeclampsia. Rev Facultad de Medicina. Caracas. 2005;28(2).

16. Rodríguez O, Riera R, Badell C. Síndrome de Hellp. Presentación de 3 Casos. Medisan. 2003;7(3).

17. Romero JP, Bolívar J, Peña E, Sabatini I, Cepeda D, Reina E. Conducta Expectante en la Preeclampsia Severa. Rev Obstet Ginecol Venezuela. Caracas. 2009;69(1).